Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

Similar articles for PubMed (Select 6460467)

1.
2.

Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.

Jankovic J, Orman J.

Neurology. 1988 Mar;38(3):391-4.

PMID:
3279337
3.

Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Jankovic J, Beach J.

Neurology. 1997 Feb;48(2):358-62.

PMID:
9040721
4.

Tetrabenazine and movement disorders.

Asher SW, Aminoff MJ.

Neurology. 1981 Aug;31(8):1051-4.

PMID:
6455607
5.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
6.

Treatment of involuntary movement disorders with tetrabenazine.

Swash M, Roberts AH, Zakko H, Heathfield KW.

J Neurol Neurosurg Psychiatry. 1972 Apr;35(2):186-91.

7.

Tetrabenazine treatment in movement disorders.

Paleacu D, Giladi N, Moore O, Stern A, Honigman S, Badarny S.

Clin Neuropharmacol. 2004 Sep-Oct;27(5):230-3.

PMID:
15602104
8.

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J.

Mov Disord. 2007 Jan 15;22(2):193-7.

PMID:
17133512
9.

Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.

Ondo WG, Hanna PA, Jankovic J.

Am J Psychiatry. 1999 Aug;156(8):1279-81.

PMID:
10450276
10.

Tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Jankovic J.

Expert Rev Neurother. 2006 Jan;6(1):7-17. Review.

PMID:
16466307
11.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Huntington Study Group.

Neurology. 2006 Feb 14;66(3):366-72.

PMID:
16476934
12.

Tetrabenazine treatment for Huntington's disease-associated chorea.

Ondo WG, Tintner R, Thomas M, Jankovic J.

Clin Neuropharmacol. 2002 Nov-Dec;25(6):300-2.

PMID:
12469001
13.

Tetrabenazine in the treatment of extrapyramidal dyskinesias.

Gilligan BS, Wodak J, Veale JL, Munro OR.

Med J Aust. 1972 Nov 4;2(19):1054-6. No abstract available.

PMID:
4264609
14.

Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.

Toglia JU, McGlamery M, Sambandham RR.

J Clin Psychiatry. 1978 Jan;39(1):81-7.

PMID:
147268
15.

Tetrabenazine: for chorea associated with Huntington's disease.

Scott LJ.

CNS Drugs. 2011 Dec 1;25(12):1073-85. doi: 10.2165/11208330-000000000-00000.

PMID:
22133328
16.

Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.

Guay DR.

Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. doi: 10.1016/j.amjopharm.2010.08.006. Review.

PMID:
20869622
17.

Tolerance of tetrabenazine during long-term treatment.

Mikkelsen BO.

Acta Neurol Scand. 1983 Jul;68(1):57-60.

PMID:
6225292
18.

Postthalamic stroke dystonic choreoathetosis responsive to tetrabenazine.

Calabrò RS, Polimeni G, Gervasi G, Bramanti P.

Ann Pharmacother. 2011 Dec;45(12):e65. doi: 10.1345/aph.1Q366. Epub 2011 Nov 24.

PMID:
22116988
19.

Alpha methylparatyrosine and tetrabenazine in movement disorders.

Lang AE, Marsden CD.

Clin Neuropharmacol. 1982 Dec;5(4):375-87.

PMID:
6130839
20.

[Therapeutic use of tetrabenazine].

López Del Val LJ, López-García E, Martínez-Martínez L, Santos-Lasaosa S.

Rev Neurol. 2009 May 16-31;48(10):523-33. Spanish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk